young doctor with digital tablet. Image courtesy of GettyImages


Our clinician led medical research brings together researchers and clinicians from academia, medical research charities, NHS Trusts, industry and patients to develop and evaluate novel treatments through single and multi-centre Phase 2 & 3 clinical trials.
Facilitated by a strong collaborative, translational approach our research focuses on addressing unmet patient needs and complex challenges in clinical medicine in the areas of cancer, clinical neuroscience and liver disease.
This research is enabled by our close working relationship with neighbouring University Hospitals Plymouth NHS Trust, one of Europe’s largest hospitals with an excellent track record for patient recruitment into clinical trials, and supported by the University of Plymouth’s UKCRC registered Peninsula Clinical Trials Unit (PenCTU) and our Medical Statistics teams.
Parkinson’s and neurodegenerative disease (Professor Camille Carroll) – clinical treatment and management, development and testing of new treatments / management tools, clinical trials and drug repurposing.
Brain tumours (Professor Oliver Hanemann) – Centre of Excellence for laboratory research and clinical studies into low grade brain tumours, development of new treatments and diagnostics.
Multiple sclerosis / patient outcome scales (Professor Jeremy Hobart) – clinical studies / trials into the assessment and treatment of MS and the design, testing and validation of patient outcome scales for clinical application.


Contact us

For more information about our clinician led medical research please contact the research leads indicated for specific areas of interest.
General enquiries:
IP, tech transfer and commercial enquiries: Dr Tom Nicholson (Research & Innovation Business Partner) or Dr David Mozley (IP Specialist Adviser).
Plymouth Science Park